Biote's acquisition of Asteria Health aims to vertically int...
Biote's acquisition of Asteria Health aims to vertically integrate manufacturing and control pharmacokinetic research. This is expected to improve margins and potentially expand therapeutic wellness products.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more